Maureen Leehey, MD
Professor Emerita, Neurology

Professor of Neurology
Chief, Movement Disorders Section
Clinic (720) 848-2080 (Use for all patient-related inquiries.)
Print Profile
Email Profile
Featured Provider Photo

Gender: Female
Languages: English
Department, Section/Division: Neurology

Practice Locations

UCHealth Neurosciences Center - Anschutz Medical Campus
1635 Aurora Ct
4th Floor
Aurora, CO 80045
720-848-2080
More providers at this location

UCHealth Lone Tree Medical Center
9548 Park Meadows Drive
Lone Tree, CO 80124
720-848-2200
More providers at this location

UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045
720-848-0000
More providers at this location

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

Specialties
  • Neurology, Board Certification (1993)
Conditions & Treatments
  • Brain and Nervous System
  • Deep Brain Stimulation
  • Movement Disorders
  • Parkinson's Disease
Clinical Interest for Patients
Dr. Leehey is a Professor of Neurology and Chief of the Movement Disorders Division at the University of Colorado Denver and a Fellow Member of the American Academy of Neurology. She specializes in movement disorders and Fragile X associated disorders and sub-specializes in movement disorders and Botox therapy. She sees patients at the University of Colorado Hospital Anschutz Centers for Advanced Medicine. She is board certified in Neurology and Psychiatry, and is a fellowship-trained movement disorders specialist. She is the senior movement disorders neurologist in the Rocky Mountain region and has mentored numerous neurologists. During her 29 years at the University of Colorado, she has managed thousands of patients with Parkinson's disease, is Lead Investigator in the International Parkinson Disease Study Group, and has been the Primary Investigator for over 20 Parkinson's disease clinical trials.

Care Philosophy
I treat people not diseases. Everyone has unique perspectives, priorities, strengths and weaknesses that are important to understand in working towards their health goals. Good communication is critical to this relationship, especially my ability to really hear patients and to communicate my thoughts in a way that is understandable. I am open to admitting when I don’t have the answers and enjoy working with a team of other clinicians.

Personal Interests
In my spare time I enjoy dance of all kinds, history, & hiking in the beautiful Colorado mountains.

Education & Training

Medical Schools:
  • MD, University of Texas Medical School at Houston (1986)

Undergraduate Schools:
  • BS, University of Texas Health Science Center at Houston (TX) (1977)

Internships:
  • St Luke's Hospital Program (1987)

Residency Program:
  • University of Colorado (University Hospital) Program, Neurology (1990)

Fellowships:
  • University of Colorado, Movement Disorders (1993)

Recognition & Awards

  • Awarded the title of Fellow Member of the American Academy of Neurology, American Academy of Neurology (2016)

Professional Memberships

  • American Academy of Neurology, Member
  • American Neurological Association, Member
  • Movement Disorder Society, Member
  • National Ataxia Foundation, Member
  • National Fragile X Foundation, Member
  • Parkinson Disease Study Group, Member
  • University of Texas Houston Medical School Alumni Association, Member

Research & Grants

http://www.ncbi.nlm.nih.gov/sites/myncbi/maureen.leehey.1/bibliograpahy/49130954/public/?sort=date&direction=ascending
Grants
  • A randomized, double-blind, placebo-controlled crossover study of tolerability and efficacy of Cannabidiol (CBD) on tremor in Parkinson’s disease (2015)
    Colorado Department of Public Health and Environment, $353005
  • A Phase 3, Open-Label Study of the Safety, Efficacy, and Tolerability of Apomorphine Administered by Continuous Subcutaneous Infusion in Advanced Parkinson’s Disease Patients with Unsatisfactory Control on Available Therapy (2015)
    US WorldMeds LLC, $250000
  • SURE-PD - A randomized, double-blind, placebo-controlled trial of urate-elevating inosine treatment to slow clinical decline in early Parkinson’s disease. (2015)
    The National Institute of Neurological Disorders and Stroke (NINDS), $75000
  • ADS-5102 (Amantadine HCl) Extending Release Efficacy and Safety Study in Parkinson’s Disease Patients with Levodopa-induced Dyskinesia (EASE LID 3 Study) (2014)
    Adamas Pharmaceuticals, $60000
Research interests for Patients:
My research is focused on Parkinson's disease, CBD/medical marijuana, and Fragile X disorders.

Information for Referring Providers

Clinical Interests for Referring Providers
I treat patients with movement disorders including Parkinson's disease, Atypical Parkinsonian Disorders, Essential Tremor, Dystonia, Ataxia, and Huntington's disease. I enjoy evaluating patients with a variety of challenging movement disorders and treating their neurological symptoms as well as frequent co-morbid psychiatric symptoms.

Research Interest for Referring Providers
My research is focused on Parkinson's disease, CBD/medical marijuana, and Fragile X disorders.
Clinic Phone: (720) 848-2080 (Use for all patient-related inquiries.)
Fax Phone: (303) 724-2212 (Use for all non-patient related fax transmissions.), (720) 848-0117 (Use for all patient-related fax transmissions, including prescription refills, referrals, and medical records.)
Office Phone: (303) 724-2194 (Use for all non-patient inquiries.)

CV Leehey CV Sept 2021.pdf